RETA
Reata Pharmaceuticals Inc - Ordinary Shares - Class A

2,864
Loading...
Loading...
Latest Earnings Results: Q3 '23
Reported: May 27

Estimated EPS

-$2.23

Reported EPS

---

Surprise

---

Estimated Rev

$25.4M

Reported Rev

---

Surprise

---

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '23
-$1.52
--
--
N/A
Q3 '23
-$2.23
--
--
N/A
Q2 '23
-$2.76
--
--
N/A
Q1 '23
-$2.39
-$3.14
-31.21%
MISSED

Latest RETA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.